MetLife Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 1/6
MetLifeDie Gewinne des Unternehmens sind mit einer durchschnittlichen jährlichen Rate von -8% zurückgegangen, während in der Branche Insurance die Gewinne wachsen. Die Umsatzerlöse sind gewachsen mit einer durchschnittlichen Rate von 1.9% pro Jahr. MetLife Die Eigenkapitalrendite des Unternehmens beträgt 13%, und die Nettomargen liegen bei 4.4%.
Wichtige Informationen
-8.02%
Wachstumsrate der Gewinne
-1.48%
EPS-Wachstumsrate
| Insurance Wachstum der Industrie | 8.02% |
| Wachstumsrate der Einnahmen | 1.87% |
| Eigenkapitalrendite | 13.00% |
| Netto-Marge | 4.43% |
| Letzte Ertragsaktualisierung | 31 Mar 2026 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
Narrativ-Update • May 03
MET: Share Repurchases And Dividend Increases Will Support Future Upside Potential
Analysts have slightly adjusted their fair value estimate for MetLife, nudging the implied price target from about $89.06 to $89.31. This reflects modest tweaks to assumptions around the discount rate, long term revenue growth, profit margin and future P/E multiples.Seeking Alpha • Apr 26
MetLife: A Great Time To Buy The Preferred Stock
Summary MetLife preferred shares now yield over 6% as rising rates pressure prices, offering attractive risk/reward for long-term investors. MET's preferred dividends are well covered, with payout ratios under 4% of adjusted earnings and likely dropping to 3% as EPS grows. Series F preferred, MET.PR.F, trades at ~$19.25 for a 6.15% yield. Low payout ratio and strong balance sheet support continued payments. Double-digit adjusted EPS growth and 15–17% ROE guidance suggest MET common shares also offer compelling upside below $80/share. Read the full article on Seeking AlphaNarrativ-Update • Apr 17
MET: Share Repurchases Following Index Exit Will Support Future Upside Potential
Analysts have slightly reduced their MetLife fair value estimate to $89.06 from $90.50, reflecting minor adjustments to assumptions for the discount rate, revenue growth, profit margin, and future P/E ratio that refine their outlook for the shares. What's in the News MetLife has been dropped from the S&P 100 index, which may influence how some index funds and benchmarks gain exposure to the stock (Key Developments).Narrativ-Update • Apr 01
MET: Share Repurchases And Index Exit Will Shape Future Upside Potential
Analysts have trimmed their average MetLife price target slightly to $90.50 from $90.73, citing updated views on revenue growth, profit margins, and future P/E assumptions. What's in the News MetLife, Inc.Narrativ-Update • Mar 18
MET: Share Repurchases Will Support Future Upside Potential
Analysts have slightly adjusted their price target for MetLife to $90.73 from $90.93, reflecting updated views on discount rates, revenue growth, profit margins, and future price-to-earnings (P/E) assumptions. What's in the News MetLife reported that from October 1, 2025 to January 31, 2026 it repurchased 7,608,263 shares, representing 1.15% of shares, for a total of US$600 million under its current buyback program (Key Developments).Narrativ-Update • Mar 04
MET: Buybacks And Retirement Income Agreements Will Drive Future Upside
Analysts have trimmed their price target on MetLife to about $90.93 from roughly $92.93. This reflects updated views on slightly lower expected revenue growth, a modestly softer profit margin, a higher discount rate, and a largely unchanged future P/E assumption.Narrativ-Update • Dec 16
MET: Retirement Income Agreements Will Drive Future Upside In Earnings Power
Analysts have marginally reduced their price target on MetLife to approximately 92.93 dollars from 93 dollars, citing a slightly higher assumed discount rate. This more than offsets modest improvements in forecast profit margins and valuation multiples.Narrativ-Update • Nov 07
MET: Revenue Will Advance On New Retirement Income And Employee Support Agreements
Analysts have slightly reduced their price target for MetLife from $93.33 to $93.00, reflecting minor adjustments to discount rate and profit margin assumptions. They maintain a positive outlook on revenue growth.Narrativ-Update • Oct 24
Digital Expansion And Employee Support Benefits Will Drive Outperformance Ahead
Analysts have modestly raised their price target for MetLife, increasing it from $93.00 to $93.33 per share. They cited slight improvements in projected revenue growth and profit margins as the reason for the adjustment.Narrativ-Update • Oct 09
International Demand And Digital Transformation Will Fuel Success
Analysts have raised their fair value estimate for MetLife from $91.86 to $93.00. This reflects slight adjustments to discount rates and growth assumptions.Narrativ-Update • Sep 04
International Demand And Digital Transformation Will Fuel Success
With no change in revenue growth forecasts or discount rate, MetLife’s fair value estimate remains steady at $91.86. What's in the News MetLife will redeem all outstanding shares of its 3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G, at $1,000 per share; dividends of $19.250 per share will be paid separately, and all further dividends cease post-redemption.Analyseartikel • Jun 11
It's Unlikely That MetLife, Inc.'s (NYSE:MET) CEO Will See A Huge Pay Rise This Year
Key Insights MetLife's Annual General Meeting to take place on 17th of June Salary of US$1.50m is part of CEO Michel...Seeking Alpha • Feb 11
MetLife: Double-Digit EPS Growth With A Single-Digit P/E, Strong Chart
Summary MetLife, Inc. is rated a buy due to its solid value, above-market dividend yield, and favorable technical chart despite recent earnings misses. Insurance stocks, including MET, have lagged behind the Financials sector and S&P 500, with premium increases expected to slow as consumers react to rising costs. MET's 2025 outlook is positive, with analysts forecasting over 17% EPS growth and 5%-6% revenue growth, despite recent underperformance in certain segments. Key risks include lower stock prices, falling interest rates, and regulatory challenges, but MET's strong investment income and share buybacks are positive factors. Read the full article on Seeking AlphaSeeking Alpha • Nov 26
MetLife Upgraded To Buy As Financials And Insurance Show Further Upside Potential
Summary MetLife stock gets upgraded to a buy, from my prior hold rating, as indicators point to further share price potential in the financials sector, as well as the insurance subsector. Data points to future continued demand for annuities and life insurance, and MetLife has in Q3 achieved new organic customer growth in 2 key businesses. Although its dividend yield is not stellar vs. peers, it has a 10-year track record of proven dividend growth, something it has potential to continue. Even though it is trading at a 10-year high, it remains undervalued on P/E and EV/EBITDA vs. peers, so continues to present a buy opportunity. Read the full article on Seeking AlphaSeeking Alpha • Sep 23
MetLife: One Of The Best Life Insurance Stocks
Summary MetLife's strong financial performance, with a 17.5% increase in adjusted EPS and a 15.2% rise in book value, makes it an attractive investment. Despite comparable performance to Aflac, MetLife's lower valuation offers better value for shareholders. MetLife's growing dividend yield and robust share buyback program enhance shareholder value, with ample cash reserves supporting future buybacks. Risks include potential commercial real estate portfolio defaults and market volatility, but MetLife's strong fundamentals and attractive valuation make it a compelling choice. Read the full article on Seeking AlphaSeeking Alpha • Jul 09
Higher For Longer? Consider MetLife's Preferred Shares With A 6.6% Yield
Summary MetLife's preferred shares, particularly the Series A with floating dividends, offer potential for investors in a 'higher for longer' inflation and interest rate environment. MetLife's strong financial performance in Q1 2021, with net profit covering preferred dividends by less than 8%. Series A preferred shares have a minimum 4% floor for dividends, with potential for higher yields based on 3 month SOFR rate adjustments. Read the full article on Seeking AlphaSeeking Alpha • Jun 26
MetLife Looks Like An Undervalued Property In An Unpopular Neighborhood
Summary MetLife shares have outperformed peers, but life insurance stocks have not really been in favor given concerns about CRE losses and rate cuts. Higher rates have allowed MetLife to reprice its investment portfolio at higher rates and sell more spread products, and the benefits will last even as rates fall. There are understandable concerns about MetLife's CRE exposure (office in particular), as the insurer is overweight here, but losses will take years to materialize and can be absorbed. MetLife's focus on profitable core businesses like group life and health, pension risk transfer, and international markets should lead to steady growth and returns for investors. This is something of a contrarian call given weak sector sentiment, but MetLife's differentiated model and ability to out-earn its cost of equity should drive outperformance. Read the full article on Seeking AlphaSeeking Alpha • Apr 18
MetLife: Healthy But Lacks Clear Advantages
Summary MetLife has experienced a decade of light shrinking instead of growth. This started as early as 2015 and was attributed to increased competition and a decrease in annuity sales, but this never seemed to improve. With their current size, competitive hurdles, and lack of clear targets for growth internationally, shares of MET will likely only give mediocre returns at best. Read the full article on Seeking AlphaAufschlüsselung der Einnahmen und Ausgaben
Aufschlüsselung der Einnahmen und Ausgaben
Wie MetLife Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
| Datum | Einnahmen | Gewinn | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
|---|---|---|---|---|
| 31 Mar 26 | 77,584 | 3,434 | 0 | 0 |
| 31 Dec 25 | 77,079 | 3,173 | 0 | 0 |
| 30 Sep 25 | 71,932 | 3,634 | 0 | 0 |
| 30 Jun 25 | 73,011 | 4,091 | 0 | 0 |
| 31 Mar 25 | 73,494 | 4,305 | 0 | 0 |
| 31 Dec 24 | 70,982 | 4,226 | 0 | 0 |
| 30 Sep 24 | 71,340 | 3,561 | 0 | 0 |
| 30 Jun 24 | 68,767 | 2,708 | 0 | 0 |
| 31 Mar 24 | 67,570 | 2,166 | 0 | 0 |
| 31 Dec 23 | 66,901 | 1,380 | 0 | 0 |
| 30 Sep 23 | 63,479 | 2,355 | 0 | 0 |
| 30 Jun 23 | 69,896 | 3,031 | 0 | 0 |
| 31 Mar 23 | 68,747 | 3,542 | 0 | 0 |
| 31 Dec 22 | 68,764 | 5,099 | 0 | 0 |
| 30 Sep 22 | 73,251 | 4,726 | 0 | 0 |
| 30 Jun 22 | 67,873 | 5,149 | 0 | 0 |
| 31 Mar 22 | 70,923 | 7,634 | 0 | 0 |
| 31 Dec 21 | 68,688 | 6,654 | 0 | 0 |
| 30 Sep 21 | 70,409 | 5,301 | 0 | 0 |
| 30 Jun 21 | 69,519 | 4,413 | 0 | 0 |
| 31 Mar 21 | 65,094 | 1,115 | 0 | 0 |
| 31 Dec 20 | 67,842 | 5,191 | 0 | 0 |
| 30 Sep 20 | 65,567 | 5,603 | 0 | 0 |
| 30 Jun 20 | 68,230 | 7,122 | 0 | 0 |
| 31 Mar 20 | 71,628 | 8,738 | 0 | 0 |
| 31 Dec 19 | 69,620 | 5,721 | 0 | 0 |
| 30 Sep 19 | 68,139 | 7,195 | 0 | 0 |
| 30 Jun 19 | 65,750 | 5,923 | 0 | 0 |
| 31 Mar 19 | 69,438 | 5,084 | 0 | 0 |
| 31 Dec 18 | 67,941 | 4,982 | 0 | 0 |
| 30 Sep 18 | 68,112 | 5,244 | -252 | 0 |
| 30 Jun 18 | 67,980 | 5,235 | -166 | 0 |
| 31 Mar 18 | 62,119 | 5,197 | 0 | 0 |
| 31 Dec 17 | 62,308 | 4,893 | 0 | 0 |
| 30 Sep 17 | 59,263 | 1,893 | -33 | 0 |
| 30 Jun 17 | 58,908 | 2,044 | -28 | 0 |
| 31 Mar 17 | 57,263 | 2,229 | -97 | 0 |
| 31 Dec 16 | 60,732 | 3,481 | 0 | 0 |
| 30 Sep 16 | 65,209 | 4,994 | 368 | 0 |
| 30 Jun 16 | 67,255 | 5,169 | 355 | 0 |
| 31 Mar 16 | 69,952 | 5,219 | 342 | 0 |
| 31 Dec 15 | 61,257 | 3,891 | 0 | 0 |
| 30 Sep 15 | 71,888 | 5,857 | 333 | 0 |
| 30 Jun 15 | 72,677 | 6,724 | 350 | 0 |
Qualität der Erträge: MET hat hohe Qualitätseinkünfte.
Wachsende Gewinnspanne: METDie aktuellen Gewinnspannen (4.4%) sind niedriger als im letzten Jahr (5.9%).
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: METDie Erträge des Unternehmens sind in den letzten 5 Jahren um 8% pro Jahr zurückgegangen.
Beschleunigtes Wachstum: METDas Unternehmen hat im vergangenen Jahr ein negatives Gewinnwachstum verzeichnet, so dass es nicht mit seinem 5-Jahres-Durchschnitt verglichen werden kann.
Erträge im Vergleich zur Industrie: MET hatte im vergangenen Jahr ein negatives Gewinnwachstum (-20.2%), was einen Vergleich mit dem Branchendurchschnitt Insurance (36.2%) erschwert.
Eigenkapitalrendite
Hohe Eigenkapitalrendite: METDie Eigenkapitalrendite des Unternehmens (13%) wird als niedrig angesehen.
Kapitalrendite
Rendite auf das eingesetzte Kapital
Entdecken Sie starke Unternehmen, die in der Vergangenheit erfolgreich waren
Unternehmensanalyse und Finanzdaten Status
| Daten | Zuletzt aktualisiert (UTC-Zeit) |
|---|---|
| Unternehmensanalyse | 2026/05/22 22:27 |
| Aktienkurs zum Tagesende | 2026/05/22 00:00 |
| Gewinne | 2026/03/31 |
| Jährliche Einnahmen | 2025/12/31 |
Datenquellen
Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.
| Paket | Daten | Zeitrahmen | Beispiel US-Quelle * |
|---|---|---|---|
| Finanzdaten des Unternehmens | 10 Jahre |
| |
| Konsensschätzungen der Analysten | +3 Jahre |
|
|
| Marktpreise | 30 Jahre |
| |
| Eigentümerschaft | 10 Jahre |
| |
| Verwaltung | 10 Jahre |
| |
| Wichtige Entwicklungen | 10 Jahre |
|
* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.
Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.
Analysemodell und Schneeflocke
Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.
Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.
Metriken für Industrie und Sektor
Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.
Analysten-Quellen
MetLife, Inc. wird von 32 Analysten beobachtet. 9 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.
| Analyst | Einrichtung |
|---|---|
| Jacob Kilstein | Argus Research Company |
| Jay Gelb | Barclays |
| Taylor Scott | Barclays |